(Bloomberg) — Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?What’s Behind the Rise in Serious Injuries on New York City’s Streets?NYC Warns of